Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von PMLiVE

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
28.03.LEO and Reig Jofre partner to improve access to psoriasis therapy in Europe
28.03.PM Society announces launch of PMi Awards 2025
28.03.Women in pharma
27.03.GSK's antibiotic Blujepa granted FDA approval to treat urinary tract infections
27.03.J&J shares overall survival results for Rybrevant/Lazcluze combination in lung cancer
27.03.FDA approves Soleno's Vykat XR as first treatment for hyperphagia in Prader-Willi syndrome
27.03.Fox&Cat appoints Kim Walker as partner and managing director
27.03.Innovation's one real law
26.03.Merck gains rights to Hengrui's heart disease candidate in deal worth almost $2bn
26.03.Sanofi's investigational MS treatment tolebrutinib granted FDA priority review
26.03.UKHSA releases list of pathogens posing 'greatest risk' to public health
26.03.Mastering KAM excellence: achieving meaningful growth from top accounts
25.03.Novo Nordisk gains rights to United Laboratories' triple receptor agonist in deal worth $2bn
25.03.Novartis' Fabhalta granted FDA approval to treat ultra-rare kidney disease C3G
25.03.GSK to explore link between Shingrix and dementia risk in new UK research collaboration
25.03.Breaking boundaries in medical affairs: how measurable outcomes redefine success
24.03.Johnson & Johnson to invest more than $55bn in US over next four years
24.03.AstraZeneca announces $2.5bn investment in China to boost R&D capabilities
24.03.Alnylam's Amvuttra granted FDA approval for rare heart disease ATTR-CM
24.03.From zero to hero: is zero-party data your new best friend for omnichannel HCP engagement?
21.03.Roche and Oxford BioTherapeutics enter oncology partnership worth over $1bn
21.03.Johnson & Johnson's Tremfya granted FDA approval to treat Crohn's disease
21.03.Almirall hosts Skin Academy to advance skin science and dermatology treatments
21.03.Omnichannel: from theory to successful implementation
20.03.Sanofi expands immunology pipeline by acquiring Dren's bispecific for $600m upfront